Coadministration of<unk>  with carbamazepine may increase exposure to carbamazepine-epoxide, the active metabolite of carbamazepine, and could theoretically lead to reduced tolerability. Coadministration of<unk>  with phenytoin may increase phenytoin levels. Coadministration of other antiseizure drugs are unlikely to affect<unk>  exposure.<unk>  provides no added therapeutic benefit when administered in conjunction with levetiracetam that acts on the same protein.
Brivaracetam
Piracetam
Phenylpiracetam
Dimiracetam
Tiagabine
Levetiracetam
Retigabine
Mesuximide